CADL logo

Candel Therapeutics, Inc. Common Stock


CADL: Candel Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing and commercializing viral immunotherapies to help patients fight cancer. The company has established two clinical-stage viral immunotherapy platforms based on novel, genetically modified adenovirus and herpes simplex virus (HSV) constructs, respectively.


Show CADL Financials

Consumer Interest
SEC Filings

Recent trades of CADL by members of U.S. Congress

Quiver Logo

No Congress Trading data for this ticker

Congress Trading Dashboard

Recently reported changes by institutional investors

Quarterly net insider trading by CADL's directors and management

Government lobbying spending instances

Quiver Logo

No Corporate Lobbying instances for this ticker

Corporate Lobbying Dashboard
U.S. Patents

New patents grants

Quiver Logo

No new patents for this ticker

U.S. Patents Dashboard
Government Contracts

Federal grants, loans, and purchases

Quiver Logo

No Government Contracts for this ticker

Government Contracts Dashboard

Number of mentions of CADL in WallStreetBets Daily Discussion


Recent insights relating to CADL

CNBC Recommendations

Recent picks made for CADL stock on CNBC

Top ETF Holders

ETFs with the largest estimated holdings in CADL

Corporate Flights

Flights by private jets registered to CADL